A novel FUS::NFATC4 fusion detected in a sarcoma with morphological features overlapping with NFATC2 sarcomas
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu dopisy
Grantová podpora
SVV260652
Ministerstvo Školství, Mládeže a Tělovýchovy
ProgramCooperatio,ResearchAreaSURG
Univerzita Karlova v Praze
PubMed
37813649
DOI
10.1111/his.15066
Knihovny.cz E-zdroje
- Klíčová slova
- FUS::NFATC4, EWSR1-non-ETS fusion, EWSR1/FUS::NFATC2 rearrangement, NFATC2-rearranged sarcoma, NFATC4-rearranged sarcoma, small round-cell sarcoma,
- MeSH
- fúzní onkogenní proteiny genetika MeSH
- lidé MeSH
- nádorové biomarkery MeSH
- nádory měkkých tkání * MeSH
- protein EWS vázající RNA MeSH
- protein FUS vázající RNA MeSH
- sarkom * diagnóza genetika MeSH
- transkripční faktory NFATC MeSH
- transkripční faktory metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
- Názvy látek
- FUS protein, human MeSH Prohlížeč
- fúzní onkogenní proteiny MeSH
- nádorové biomarkery MeSH
- NFATC2 protein, human MeSH Prohlížeč
- NFATC4 protein, human MeSH Prohlížeč
- protein EWS vázající RNA MeSH
- protein FUS vázající RNA MeSH
- transkripční faktory NFATC MeSH
- transkripční faktory MeSH
Bioptical Laboratory Ltd Plzen Czech Republic
Cytopathos Ltd Bratislava Slovakia
Department of Pathology Charles University Faculty of Medicine in Plzen Plzen Czech Republic
Department of Pathology Johns Hopkins University School of Medicine Baltimore MD USA
Zobrazit více v PubMed
Kallen ME, Hornick JL. The 2020 WHO classification: what's new in soft tissue tumor pathology? Am. J. Surg. Pathol. 2021; 45; e1-e23.
Michal M, Rubin BP, Agaimy A et al. EWSR1-PATZ1-rearranged sarcoma: a report of nine cases of spindle and round cell neoplasms with predilection for thoracoabdominal soft tissues and frequent expression of neural and skeletal muscle markers. Mod. Pathol. 2021; 34; 770-785.
Perret R, Escuriol J, Velasco V et al. NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker. Mod. Pathol. 2020; 33; 1930-1944.
Torres-Mora J, Fritchie K, Folpe AL et al. Soft tissue and bone tumors with EWSR1/FUS::NFATC2 gene fusions: a clinico-pathologic study of 28 cases emphasizing their broad morphologic spectrum. Lab. Invest. 2023; 103; S72.
Wang GY, Thomas DG, Davis JL et al. EWSR1-NFATC2 translocation-associated sarcoma clinicopathologic findings in a rare aggressive primary bone or soft tissue tumor. Am. J. Surg. Pathol. 2019; 43; 1112-1122.
Genecards-the human gene database (database online). NFATC4 gene. 2023. Available at: https://www.genecards.org/cgi-bin/carddisp.pl?gene=NFATC4#paralogs.
Zhong Q-H, Zha S-W, Lau ATY, Xu Y-M. Recent knowledge of NFATc4 in oncogenesis and cancer prognosis. Cancer Cell Int. 2022; 22; 212.
